AI-generated summary
The authors studied 22 patients with myofascial pain dysfunction syndrome treated with low-level gallium-aluminum-arsenide laser in a quasi-experimental design. They report significant improvement in pain severity, pain frequency and masticatory muscle tenderness at the end of four weeks of treatment, sustained over a three-month follow-up.
- Participants
- 22
- Who or what was studied
- Patients with myofascial pain dysfunction syndrome referred to the Department of Oral Medicine, Tehran University of Medical Sciences Faculty of Dentistry
- Limits stated in the abstract
- The study was quasi-experimental with a small sample of 22 patients, and the abstract does not describe a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.